State Rx Assistance Programs Should Contract With Part D Plans, CMS Says
Executive Summary
The Centers for Medicare & Medicaid Services is encouraging state pharmaceutical assistance programs to pay Medicare prescription drug plans a risk-based per capita lump sum to provide wrap-around coverage for low-income beneficiaries
You may also be interested in...
SPAP Qualification Checklist Due Sept. 2; CMS Offers “Rich Data Exchange”
State pharmaceutical assistance programs must attest that they do not already receive federal funds, according to a checklist CMS is directing SPAPs to consult when seeking "qualified" status for Medicare Part D
SPAP Qualification Checklist Due Sept. 2; CMS Offers “Rich Data Exchange”
State pharmaceutical assistance programs must attest that they do not already receive federal funds, according to a checklist CMS is directing SPAPs to consult when seeking "qualified" status for Medicare Part D
Manufacturer Part D Patient Assistance Should Be Cash, Not Donated Drugs
Manufacturers should provide financial assistance for Medicare Part D beneficiaries through cash donations to charities rather than by donating products, the Centers for Medicare & Medicaid Services says